uMhlabangubo

Bidens pilosa contains polyacetylenes, flavonoids (including rutin and hyperoside), sesquiterpene lactones, and 4,5-O-dicaffeoylquinic acid that collectively drive antioxidant, anti-inflammatory, and antimicrobial activity through free radical scavenging and inhibition of microbial growth. Leaf and flower extracts demonstrate the strongest radical-scavenging potency, with DPPH IC50 values as low as 13.35–35.35 µg/mL and total polyphenol content reaching up to 179.31 mg GAE/g in leaf fractions, comparable in inhibition percentage to ascorbic acid at 55.17–88.12%.

Origin & History

Bidens pilosa is a pantropical annual herb in the Asteraceae family, native to South America but now widely naturalized across sub-Saharan Africa, Asia, and other tropical and subtropical regions. In southern Africa, it grows prolifically in disturbed soils, roadsides, agricultural margins, and forest edges from sea level to high-altitude grasslands, thriving in full sun with moderate moisture. It is not formally cultivated but is routinely harvested from wild populations, with leaves and flowers collected at peak growth for maximum bioactive yield.

Historical & Cultural Context

In Zulu ethnomedicine, Bidens pilosa is known as uMhlabangubo and has been used for generations as a multipurpose therapeutic plant to treat infertility, diarrhoea, colic, rheumatism, syphilis, malaria, and coughs, representing one of the most versatile plants in southern African traditional pharmacopoeia. Across sub-Saharan Africa, East Africa, and parts of Asia, the plant holds parallel significance: in Kenya it is consumed as a leafy vegetable and applied medicinally against malaria and wounds, while in China it is documented in traditional herbal texts for fever and inflammation. Healers typically prepare fresh leaf poultices for topical wounds and skin conditions alongside oral decoctions for systemic complaints, with preparation methods transmitted orally across generations. The plant's widespread distribution, ease of collection, and broad therapeutic reputation have made it a key subject of modern African ethnopharmacology research aimed at validating and standardising its traditional applications.

Health Benefits

- **Antioxidant Protection**: Leaf and flower fractions deliver total polyphenol content up to 179.31 mg GAE/g and DPPH IC50 values as low as 13.35 µg/mL, reflecting potent free radical scavenging attributed to rutin, hyperoside, and caffeic acid derivatives.
- **Anti-inflammatory Activity**: Flavonoids including rutin and hyperoside neutralize reactive oxygen species and modulate pro-inflammatory pathways; in vitro extracts elevate cytokines IL-1α and IL-1β, suggesting immunomodulatory signalling rather than simple suppression.
- **Antimicrobial and Antiparasitic Effects**: Polyacetylenes and sesquiterpene lactones disrupt the growth of bacterial and parasitic pathogens; this underpins traditional use against diarrhoea, colic, syphilis, and malaria across rural African communities.
- **Potential Anticancer Activity**: HepG2 hepatocellular carcinoma cell assays show that extracts suppress Raf-1 and MEK-1 gene expression and downregulate autophagy-related genes Atg12 and LC3B, inducing programmed cell death without detectable cytotoxicity to normal cells.
- **Antimalarial Support**: Ethnopharmacological records and in vitro evidence support antiprotozoal activity linked to polyacetylene and flavonoid fractions, consistent with widespread traditional use of leaf decoctions against malarial fevers in southern and East Africa.
- **Digestive and Antidiarrhoeal Use**: Traditional preparations are used to relieve diarrhoea and colic; antimicrobial activity against enteric pathogens from polyacetylenes provides a plausible mechanistic basis for these gastrointestinal applications.
- **Cough and Respiratory Relief**: Aqueous and hydroethanolic leaf extracts are applied traditionally to manage coughs; anti-inflammatory flavonoids may reduce airway inflammation, although this mechanism has not yet been confirmed in clinical settings.

How It Works

Polyacetylenes and sesquiterpene lactones disrupt microbial cell integrity and inhibit the growth of pathogenic microorganisms, providing the antimicrobial and antiparasitic basis for traditional use. Flavonoids such as rutin and hyperoside, alongside 4,5-O-dicaffeoylquinic acid, scavenge free radicals and modulate oxidative stress through direct hydrogen-atom donation, with antioxidant capacity correlating positively with total flavonoid content (TFC) and total polyphenol content (TPC) across plant fractions. At the molecular level, extracts inhibit expression of Raf-1 and MEK-1 oncogenes in HepG2 cells — key nodes of the MAPK/ERK proliferation pathway — while simultaneously downregulating autophagy genes Atg12 and LC3B, tipping the balance toward apoptotic cell death. Additionally, extracts elevate pro-inflammatory cytokines IL-1α and IL-1β, suggesting a context-dependent immunostimulatory role that may contribute to antimicrobial host defence.

Scientific Research

The evidence base for Bidens pilosa is entirely preclinical, consisting of in vitro phytochemical analyses, radical-scavenging assays, and cell-line experiments; no published human clinical trials with defined sample sizes or effect sizes are available. HPLC-based phytochemical profiling has quantified TPC at 9.03–179.31 mg GAE/g in leaf extracts and confirmed the presence of rutin, hyperoside, paclitaxel, and polyacetylenes, with leaves and flowers consistently outperforming stems and roots across populations. Antioxidant capacity has been measured by DPPH assay with IC50 values of 13.35–35.35 µg/mL for leaf/flower fractions, while anticancer mechanistic work in HepG2 cells documented Raf-1/MEK-1 suppression and autophagy gene modulation at extract concentrations of 5–100 µg/mL. The overall evidence quality is low-to-moderate for mechanistic insight but insufficient for clinical dosing recommendations or therapeutic claims in humans.

Clinical Summary

No controlled human clinical trials have been conducted on Bidens pilosa for any of its primary traditional indications including infertility, malaria, diarrhoea, or cancer. Available data derive from in vitro cell-line studies (e.g., HepG2 hepatocellular carcinoma assays), phytochemical quantification studies, and ethnobotanical surveys, none of which provide effect sizes applicable to human populations. The most quantified outcomes are antioxidant IC50 values and gene expression changes in cancer cell lines, which, while mechanistically informative, do not translate directly to clinical efficacy or safety parameters. Confidence in therapeutic outcomes for humans remains very low, and any use should be regarded as traditional or investigational pending formal clinical investigation.

Nutritional Profile

Bidens pilosa leaves provide modest macronutrient content typical of leafy vegetables, including protein, dietary fibre, and low fat levels, though precise macronutrient values in standardised per-gram formats are not extensively published. Phytochemically, leaves are the richest fraction, containing total polyphenols at 9.03–179.31 mg GAE/g (dry weight, varying by population and extraction method), total flavonoids including rutin and hyperoside, polyacetylenes detectable at UV maxima of 256, 270, 305, 326, 348, and 378 nm, sesquiterpene lactones, 4,5-O-dicaffeoylquinic acid, and notably paclitaxel — a clinically significant taxane first detected in this species' leaves. Bioavailability of flavonoids and polyphenols from aqueous preparations is expected to be moderate, enhanced by co-ingestion with dietary fats that facilitate absorption of lipophilic polyacetylenes; however, no formal human bioavailability studies have been conducted for this plant.

Preparation & Dosage

- **Traditional Aqueous Decoction**: Leaves and/or flowers are boiled in water and the liquid consumed; this is the most common preparation across southern and East African traditional medicine, with volumes varying by practitioner but typically 1–2 cups daily.
- **Hydroethanolic Maceration (Research Standard)**: Laboratory studies employ 50–70% ethanol–water maceration of dried leaf or flower material to optimise extraction of flavonoids, polyacetylenes, and polyphenols; no commercial standardised extract currently exists.
- **Methanol Extract (Research Use Only)**: Methanol extracts used in in vitro assays at 5–100 µg/mL for antioxidant and cytotoxicity testing; not suitable for direct human consumption in this solvent form.
- **Plant Part Selection**: Leaves and flowers contain the highest TFC, TPC, and antioxidant activity (IC50 13.35–35.35 µg/mL) and are preferred over stems or roots for any preparation.
- **No Standardised Commercial Dose**: No clinically validated dose, standardisation percentage, or licensed supplement form has been established; dosing guidance cannot be responsibly provided beyond traditional ethnobotanical references.
- **Timing**: Traditional preparations are typically consumed in the morning or after meals; no pharmacokinetic data exist to guide optimised dosing windows.

Synergy & Pairings

Bidens pilosa's flavonoid and polyphenol content may synergise with other antioxidant-rich botanicals such as Moringa oleifera or green tea (Camellia sinensis), as combined polyphenol pools can enhance cumulative free radical scavenging capacity beyond additive effects through complementary radical-quenching mechanisms. The antimalarial polyacetylenes in Bidens pilosa have been suggested in ethnobotanical literature to complement artemisinin-based therapies when used in traditional multi-herb preparations, though no pharmacological confirmation of this combination exists. For anti-inflammatory applications, pairing with curcumin (from Curcuma longa) could theoretically reinforce NF-κB and MAPK pathway modulation, as both target overlapping inflammatory signalling nodes, but this combination has not been clinically evaluated.

Safety & Interactions

The safety profile of Bidens pilosa in humans is poorly characterised due to the absence of clinical trials; the only formal cytotoxicity data available from in vitro HepG2 cell studies found no detectable cytotoxicity at tested extract concentrations, which provides limited but preliminary reassurance. No specific drug interactions have been identified in the published literature, though the plant's flavonoid content, CYP enzyme modulation potential, and immunomodulatory cytokine activity (IL-1α and IL-1β elevation) suggest theoretical interactions with immunosuppressants, anticoagulants, and chemotherapeutic agents that warrant caution. Contraindications are not formally established, but traditional use in pregnancy for treating infertility-related conditions should be approached cautiously given the absence of reproductive safety data, and use during lactation is not supported by evidence. Maximum safe doses have not been determined for any population group, and individuals should consult a qualified healthcare provider before using this plant therapeutically.